• Kymab, Roche Partner to Evaluate KY1044 contractpharma
    July 03, 2018
    Kymab Group Ltd has entered a clinical trial agreement with Roche. Under the agreement, Roche will provide its PD-L1 blocking antibody atezolizumab for use in combination in Kymab’s upcoming Phase I-II clinical studies combining
PharmaSources Customer Service